The Valley Desk

ArticleThe Journal of biological chemistryPublished

A covalent inhibitor targeting Cys-349 of LIMK1 confers selectivity over LIMK2

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source

Institution
Merck & Co.

Publication record

Type
Article
Venue
The Journal of biological chemistry
Published
Subject terms
Humans; Cysteine; Protein Kinase Inhibitors; Crystallography, X-Ray; Lim Kinases; Pharmacology; Crystallography; SPR; kinase; Inhibition Mechanism
PubMed ID
42442493
PubMed Central ID
PMC13519618
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal